Immunization with heat-killed Mycobacterium bovis bacille Calmette–Guerin (BCG) in Eurocine™ L3 adjuvant protects against tuberculosis

This publication has 27 references indexed in Scilit:

• Genetically Determined Disparate Innate and Adaptive Cell-Mediated Immune Responses to PulmonaryMycobacterium bovisBCG Infection in C57BL/6 and BALB/c Mice
  Infection and Immunity, 2000
• Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride/fatty acid lipid suspensions as adjuvants
  Vaccine, 1999
• Human cytolytic and interferon γ-secreting CD8⁺T lymphocytes specific forMycobacterium tuberculosis
  Proceedings of the National Academy of Sciences, 1998
• CTL induction using synthetic peptides delivered in emulsions— critical role of the formulation procedure
  Vaccine, 1997
• Immunogenetics in the analysis of resistance to intracellular pathogens
  Current Opinion in Immunology, 1995
• Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I‐ and II‐deficient knock‐out mice: contribution of CD4 and CD8 T cells to acquired resistance
  European Journal of Immunology, 1995
• Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
  JAMA, 1994
• Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis
  International Journal of Epidemiology, 1993
• T Cell Response to Mycobacterium tuberculosis
  The Journal of Infectious Diseases, 1993
• Adjuvants — a balance between toxicity and adjuvanticity
  Vaccine, 1993